Skip to main content

Table 1 Comparative ORs for vaping vs. cigarette smoking

From: Comparing smoking-related disease rates from e-cigarette use with those from tobacco cigarette use: a reanalysis of a recently-published study

Study

Disease

Estimate from source

Estimate in Fig. 1 of Glantz et al. [14]

Alzahrani [34]

MI

0.66 (0.43–1.02)

Same

Falk [23]

 

0.35 (0.19–0.63)

0.35 (0.19–0.62)

Farsalinos [33]

 

0.43 (0.25–0.75)

Only gave CHD estimate

Goldberg Scott [26]

 

Not available1

No

Hirschtick [24]

 

0.31 (0.06–1.60)

0.30 (0.04–2.22)

Pooled

 

0.48 (0.35–0.67)

Same2

Bricknell [35]

Stroke

0.77 (0.54–1.10)

Same

Falk [23]

 

0.50 (0.27–0.92)

0.50 (0.33–0.77)

Goldberg Scott [26]

 

Not available1

No

Hirschtick [24]

 

0.77 (0.23–2.61)

0.77 (0.25–2.38)

Parekh [36]

 

0.43 (0.20–0.95)

0.43 (0.18–1.04)

Pooled

 

0.65 (0.49–0.86)

0.62 (0.48–0.82)

Antwi [39]

COPD

0.32 (0.23–0.45)

0.32 (0.22–0.47)

Barrameda [40]

 

0.76 (0.31–1.89)

No

Cook [42]

 

0.67 (0.42–1.09)

0.67 (0.39–1.17)

Kim [44]

 

Not available3

No

Osei [45]

 

Not available1

No

Parekh [46]

 

0.42 (0.21–0.84)

0.42 (0.17–1.01)

Paulin [47]

 

0.71 (0.26–1.91)

0.71 (0.23–2.23)

Perez [48]

 

Not available1

No

Wills [49]

 

0.87 (0.44–1.71)

0.86 (0.46–1.61)

Wills [50]

 

0.31 (0.26–0.38)

Same

Xie [52]

 

0.39 (0.27–0.56)

0.39 (0.25–0.62)

Pooled

 

0.46 (0.35–0.60)

0.46 (0.35–0.62)4

  1. 1 Paper gave no ORs for those who smoked cigarettes
  2. 2 Including the estimate we extracted from Farsalinos [33]
  3. 3 Paper did not separate out those who only vaped
  4. 4 Including the estimate we derived from Barrameda [40]